期刊文献+

EXPRESSION OF P53 PROTEIN AND PROLIFERATING CELL NUCLEAR ANTIGEN IN HUMAN GESTATION TROPHOBLASTIC DISEASE 被引量:2

EXPRESSION OF P53 PROTEIN AND PROLIFERATING CELL NUCLEAR ANTIGEN IN HUMAN GESTATION TROPHOBLASTIC DISEASE
下载PDF
导出
摘要 To study the relationship between p53 protein, proliferating cell nuclear antigen (PCNA) expression and benign or malignant gestational trophoblastic disease (MGTD). Methods: The histotomic sections of 48 patients with gestational trophoblastic disease and 24 patients of normal chorionic villi were stained using immunohistochemistry. The monoclonal antibodies were used to determine p53 protein and PCNA. Results: The frequency of p53 and PCNA positive expression were significantly different among the chorionic villi of normal pregnancy, hydratidiform mole (HM) and MGTD. But neither p53 nor PCNA has any relation with the clinical staging or metastasis of MGTD. Conclusion: Both P53 and PCNA are valuable in diagnosis of human gestational trophoblastic disease. To study the relationship between p53 protein, proliferating cell nuclear antigen (PCNA) expression and benign or malignant gestational trophoblastic disease (MGTD). Methods: The histotomic sections of 48 patients with gestational trophoblastic disease and 24 patients of normal chorionic villi were stained using immunohistochemistry. The monoclonal antibodies were used to determine p53 protein and PCNA. Results: The frequency of p53 and PCNA positive expression were significantly different among the chorionic villi of normal pregnancy, hydratidiform mole (HM) and MGTD. But neither p53 nor PCNA has any relation with the clinical staging or metastasis of MGTD. Conclusion: Both P53 and PCNA are valuable in diagnosis of human gestational trophoblastic disease.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2004年第2期147-149,共3页 中国癌症研究(英文版)
关键词 p53 protein Proliferating cell nuclear antigen (PCNA) Gestational trophoblastic disease(GTD) p53 protein Proliferating cell nuclear antigen (PCNA) Gestational trophoblastic disease(GTD)
  • 相关文献

参考文献9

  • 1Camplejohn,RS,Rutherford,J.p53 functional assays: detecting p53 mutations in both the germline and in sporadic tumors[].Cell Proliferation.2001
  • 2Salvesen HB,Akslen LA.Molecular pathogenesis and prognostic factors in endometrial carcinoma[].Acta Pathologica Microbiologica et Immunologica Scandinavica.2002
  • 3R Brown,C Clugston,P Burns,A Edlin,P Vasey,B Vojtesek,SB Kaye.Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines[].International Journal of Cancer.1993
  • 4GotliebWH,WatsonJM,RezaiA,etal.Cytokine-inducedmodulationoftumorsuppresorgeneexpresioninovariancan-cercels:Up-regulationofp53geneexpressionandinductionofapoptosisbytumornecrosisfactor-α[].American Journal of Obstetrics and Gynecology.1994
  • 5Berker,B,Dunder,I,Ensari,A.Prognostic significance of apoptotic index and bcl-2 and p53 expression in epithelial ovarian carcinoma[].European Journal of Gynaecological Oncology.2002
  • 6Campomenosi,P,Hall,PA.Gadd45 mutations are uncommon in human tumour cell lines[].Cell Proliferation.2000
  • 7LeuineAJ,MomandJ,FinlayCA, et al.TheP53 tumor suppressor gene[].Nature.1991
  • 8SoussiT,CaronFC,MayP, et al.Structural aspects ofP53 protein in relation in gene evolution[].Oncegene.1990
  • 9SchuijerM,BernsEM.TP53 and ovarian cancer[].Human Mutation.2003

同被引文献23

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部